| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
3
| CZEREPAK ELIZABETH (See Remarks) has filed a Form 3 on Vickers Vantage Corp. I |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| CZEREPAK ELIZABETH (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $6.01, valued at
$601k
|
|
| 11/18/2021 |
3
| CZEREPAK ELIZABETH (Director) has filed a Form 3 on Sorrento Therapeutics, Inc. |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| CZEREPAK ELIZABETH (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 20,000 options to buy
@ $11.67, valued at
$233.4k
|
|
| 06/19/2020 |
4
| CZEREPAK ELIZABETH (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC|
Txns:
| Granted 30,000 shares
@ $0
Granted 60,000 options to buy
@ $2.94, valued at
$176.4k
|
|
| 02/24/2020 |
3
| CZEREPAK ELIZABETH (Director) has filed a Form 3 on DELCATH SYSTEMS, INC. |
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/26/2017 |
4
| CZEREPAK ELIZABETH (CFO and EVP Corp. Development) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 62,500 options to buy
@ $2.48, valued at
$155k
|
|
| 05/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |